Abstract
A collaboration between The University of Texas MD Anderson Cancer Center in Houston and the Broad Institute of MIT and Harvard in Cambridge, MA, is tackling rare cancers. The institutions have created a research platform to generate rare cancer models based on patients' tumor samples, which researchers will sequence to reveal the genomics of the diseases and identify potential therapeutic targets.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
